Overcoming the barriers to scale-up in cell therapy manufacturing  

Innovations in clinical trials design for gene therapies  

Scaling allogeneic: Making off-the-shelf cell therapies work 

Addressing regulatory bottlenecks for advanced therapies  

The role of AI in therapy development and manufacturing  

Funding strategies for early-stage cell and gene therapy companies 

Navigating patient access & reimbursement for high-cost therapies  

Investor expectations: what do you need for each funding stage?  

Building the right team – who should be involved at each development stage?  

Intellectual property and commercialisation strategies